220. Rapidly progressive glomerulonephritis Clinical trials / Disease details
Clinical trials : 2 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathway : 1
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00354198 (ClinicalTrials.gov) | August 2006 | 18/7/2006 | Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis | Clinical Efficacy of Combined Pentoxifylline and Conventional Immunosuppressive Regimens on Patients With Rapidly Progressive Glomerulonephritis | Glomerulonephritis | Drug: pentoxifylline;Drug: corticosteroids | National Taiwan University Hospital | National Science Council, Taiwan | Terminated | 20 Years | 80 Years | Both | 7 | Phase 3 | Taiwan |